Showing results (71-80 of 93) with videos related to
Sort By:
Pageof 10
Neurology|September 25, 2003
Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypesG Burke, J Cossins, S Maxwell, et al.Pilot and Feasibility Studies|February 7, 2018
A protocol for a randomised double-blind placebo-controlled feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue in people with relapsing and remitting multiple sclerosis (RRMS)S Coe, J Collett, H Izadi, et al.Neurology|February 4, 2012
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assaysP J Waters, A McKeon, M I Leite, et al.Neuromuscular Disorders : NMD|October 19, 2010
Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myastheniaP Munot, D Lashley, H Jungbluth, et al.BMJ Open|May 27, 2015
Protocol for a multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin versus standard therapy for the treatment of transverse myelitis in adults and children (STRIVE)M Absoud, J Gadian, J Hellier, et al.Neurology|July 14, 2004
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitisR Watson, Y Jiang, I Bermudez, et al.Journal of Neurology|November 16, 2007
MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findingsA Seewann, C Enzinger, M Filippi, et al.Journal of Neuroimmunology|August 19, 2008
Congenital myasthenic syndromes in childhood: diagnostic and management challengesM Kinali, D Beeson, M C Pitt, et al.Neurology|January 8, 2010
MRI criteria for MS in patients with clinically isolated syndromesX Montalban, M Tintoré, J Swanton, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 23, 2002
Intravenous immunoglobulin in neurological disease: a specialist reviewC M Wiles, P Brown, H Chapel, et al.Pageof 10